25 – 27 March 2026
TRAINING TIMES
to ensure nucleic acid product quality and compliance.
for product characterization and stability assessment.
processes and facilities specific to nucleic acid drugs.
and lifecycle management effectively.
Three days of expert-led Zoom sessions packed with discussions, Q&As, and real-world scenarios.
All slides, tools, and supporting materials available in our CLIENT ZONE before, during, and after the course.
Receive a digital certificate (also Linkedin-ready) that verifies your skills in strategic trial planning.
Designed for professionals who want to enhance their expertise and advance their careers
CMC Expert and Independent Consultant Len has over 30 years of experience in both industry and academia. He is a member of a regulatory advisory group for ATMPs. Len has been a company founder, COO and GMP site head/license holder, overseeing biopharma development and manufacture as well as outsourced CDMO activities. Len has undertaken development and manufacturing of 18 new biological entities, including first-in-man/first-in-class cell and gene therapies, viral vectors, biologics, and monoclonal antibodies. Len’s regulatory and licensing experience covers the MHRA, EMA and FDA. Len works as a CMC consultant for small and large pharmaceutical companies. We are live on webchat!
Learn More →
Watch the video invitation from the trainer.
Take a sneak peek at the trainer's presentation.
View PDF →